Roche Holding Ltd.

Pharmaceuticals
Switzerland
Executive 1Dr. Severin Schwan, Chief Executive Officer; | Chief Executive Officer;
Executive 2Dr. Alan Hippe, Chief Financial Officer; Officer | N/A
Earnings Per Share Growth (%)-16.40%
Cost of Goods Sold (US$ Millions)$13,527
Current Liabilities (US$ Millions)$23,361
Total Assets (US$ Millions)$31,454
Long Term Debt (Millions)$19,558
Return on Equity49.42%
Revenue (US$ Millions)$50,411
Total Company Assets$76,468
Revenue Growth (%)2.58%
Net Income (US$ Millions)$9,639
Earnings Per Share (US$)$10.93
Total Equity (US$ Millions)$19,800
Profit Margin (%)19.12%
Debt To Equity Ratio (%)0.99%
Inventories (Millions)$7,828